Portugal, Aug. 19 -- Portugal based CENCORA 3PL PORTUGAL, S.A. has secured contract from Instituto Portugues De Oncologia Do Porto Francisco Gentil, Epe for Adcm 2392/26 - Bevacizumab (Bio Abevmy) 25Mg/Mlconcp/Infusion Frs 16Ml Iv - Ne 1378526 . The value of the contract is worth 26185 EUR .
Published by HT Digital Content Services with permission from Pivotal Sources....